Nowadays, I have been developing my professional career at Takeda´s PVPA (Patient Value, Policy and Access) team, after leaving Biogen, after developing in IBERIA and during three years, an European joint venture based on Biosimilars Business Unit (BBU).

Previously, I had the chance of developing different roles (Sales & Access) at Orion Pharma, Nutricia, Grunenthal, Rottapharm and Cinfa.

New times, new ways of doing and innovation in Market Access, apart from new Life- Sciences & healthcare (L&H) legal scenarios, are sending mandatory signals and alerts to Boards and Staff members at L&H Companies to maintain constant education and adaptation in front of new Payers and Decision Makers´ needs., in any case: Public, Private or Hybrid ones.

That´s the reason why I took the decision of being involved on different Post- grade Education Programs: Health and Drug Economy (Pompeu- Fabra University). Advanced Management Program (IE Business School), apart from improving my English level at Cambridge English levels. My original Degree Education is Policy Sciences and Sociology.

As a new role in high education since May 2021, I´m part of Teacher´s Panel at Francisco de Vitoria University, collaborating on Master Patient Access to Medicines Value and Healthcare Technologies”. And also taking part in Teacher´s panel at IMF Smart Education project, collaborating with International MSL Master.

All this information: on the one hand, at Life Sciences & Healthcare Companies. On the other hand, at start up level I have been involved as a Board Member of a SportsTECH Project born in IE Business Schools´ class.

More details of interest: • SEDISA member (Healthcare Manager Spanish Society), since 2011. • SEFH member (Hospital Pharmacy Spanish Society), since 2015. • The Professional Society for Health Economics and Outcomes Research (ISPOR) member, since 2021.

Medium member since July 2021
Editor of Jose A. Vidal



Connect with JOSÉ A. VIDAL